Loading clinical trials...
Loading clinical trials...
A Phase II Trial Using Amifostine as a Chemo/Radio Protective Agent in the Treatment of Limited Stage Small-Cell Lung Cancer
Conditions
Interventions
amifostine trihydrate
cisplatin
+2 more
Locations
1
United States
University of Florida - Gainesville
Gainesville, Florida, United States
Start Date
June 1, 1997
Last Updated
December 4, 2013
NCT06498635
NCT05692635
NCT07485114
NCT06066138
NCT06305754
NCT05198830
Lead Sponsor
University of Florida
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions